OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial-Reference-Cited by-同舟云学术

OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial

Published:2013-06 Issue:6 Volume:189 Page:2186-2193
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Nitti Victor W.¹,Dmochowski Roger²,Herschorn Sender³,Sand Peter⁴,Thompson Catherine⁵,Nardo Christopher⁶,Yan Xiaohong⁶,Haag-Molkenteller Cornelia⁶,

Affiliation:

1. New York University Urology Associates, New York, New York

2. Vanderbilt University, Nashville, Tennessee

3. University of Toronto, Toronto, Ontario, Canada

4. University of Chicago, Evanston, Illinois

5. Allergan, Ltd., Marlow, Buckinghamshire, United Kingdom

6. Allergan, Inc., Irvine, California

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference21 articles.

1. Prevalence and burden of overactive bladder in the United States;Stewart;World J Urol,2003

2. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study;Irwin;Eur Urol,2006

3. Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women;Lawrence;Obstet Gynecol,2008

4. How widespread are the symptoms of an overactive bladder and how are they managed?;Milsom;BJU Int,2001

5. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction;Haylen;Int Urogynecol J,2010

Cited by 364 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Botulinum toxin therapy in urology: historical aspect;Urology reports (St. - Petersburg);2024-08-08

2. Adverse Effects of Intravesical OnabotulinumtoxinA Injection in Patients with Idiopathic Overactive Bladder or Neurogenic Detrusor Overactivity: A Systematic Review and Meta-Analysis of Randomized Controlled Studies;Toxins;2024-08-05

3. Results of a study examining the use of onabotulinumtoxinA in pediatric patients with overactive bladder;Journal of Pediatric Urology;2024-08

4. Efficacy, Satisfaction, and Compliance: Insights from 15 Years of Botulinum Toxin Use for Female Urgency Urinary Incontinence;Toxins;2024-07-26

5. The AUA/SUFU guideline on the diagnosis and treatment of idiopathic overactive bladder;Neurourology and Urodynamics;2024-07-15